Evidence map›Paper›PMID 38392991›Full record

ArticleMetabolites2024

Optimization of Fermentation Process for New Anti-Inflammatory Glycosylceramide Metabolite from

Yung-Husan Chen, Qiaoqiao Zhu, Jingyi Li, Rong Yang, Jingwen Zhang, Minxin You, Lianzhong Luo, Bingye Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Marine natural products.Natural product reports · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yung-Husan ChenXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.ORCID 0000-0001-7431-1344
Qiaoqiao ZhuXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Jingyi LiXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Rong YangXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Jingwen ZhangXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Minxin YouXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Lianzhong LuoXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Bingye YangXiamen Key Laboratory of Natural Products Resources of Marine Medicine, Xiamen Medical College, Xiamen 361023, China.
Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel ceramide compound, named Aspercerebroside A (AcA), was successfully isolated from the ethyl acetate layer of the marine symbiotic fungus

Indexed as

Aspergillus sp.fermentation optimizationglycosylceramidorthogonal experimentsresponse surface optimization

Identifiers

PMID38392991
PMCPMC10890386
OpenAlexW4391404366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.